Free Trial

Universal Beteiligungs und Servicegesellschaft mbH Takes $2.12 Million Position in Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Maximus, Inc. (NYSE:MMS - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 31,014 shares of the health services provider's stock, valued at approximately $2,115,000. Universal Beteiligungs und Servicegesellschaft mbH owned 0.05% of Maximus as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Y Intercept Hong Kong Ltd bought a new position in Maximus in the first quarter worth approximately $1,747,000. South Dakota Investment Council grew its position in shares of Maximus by 16.2% during the 1st quarter. South Dakota Investment Council now owns 14,264 shares of the health services provider's stock worth $973,000 after buying an additional 1,989 shares in the last quarter. Verdence Capital Advisors LLC increased its stake in shares of Maximus by 54.3% during the first quarter. Verdence Capital Advisors LLC now owns 7,469 shares of the health services provider's stock valued at $509,000 after buying an additional 2,629 shares during the period. Victory Capital Management Inc. raised its holdings in shares of Maximus by 7.7% in the first quarter. Victory Capital Management Inc. now owns 41,228 shares of the health services provider's stock valued at $2,811,000 after acquiring an additional 2,931 shares in the last quarter. Finally, Edgestream Partners L.P. raised its holdings in shares of Maximus by 139.4% in the first quarter. Edgestream Partners L.P. now owns 18,217 shares of the health services provider's stock valued at $1,242,000 after acquiring an additional 10,609 shares in the last quarter. 97.21% of the stock is owned by institutional investors.

Maximus Stock Down 1.4%

NYSE MMS traded down $1.02 during trading on Friday, hitting $72.84. The company's stock had a trading volume of 509,770 shares, compared to its average volume of 422,065. The company has a market cap of $4.10 billion, a PE ratio of 14.48 and a beta of 0.60. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.94. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.84 and a quick ratio of 1.84. The business's 50 day simple moving average is $71.31 and its 200-day simple moving average is $70.50.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The firm had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.29 billion. During the same period last year, the business posted $1.57 earnings per share. The company's revenue for the quarter was up 1.0% compared to the same quarter last year. On average, equities analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Sunday, August 31st. Shareholders of record on Friday, August 15th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.6%. The ex-dividend date is Friday, August 15th. Maximus's dividend payout ratio is currently 23.86%.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

View Our Latest Stock Report on Maximus

Insider Activity at Maximus

In other news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the sale, the director directly owned 14,205 shares in the company, valued at $1,028,157.90. This trade represents a 35.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is owned by insiders.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines